General Information of the Compound
Compound ID
CP0547089
Compound Name
6-[6-[3-(5-methylpyrazol-1-yl)propoxy]pyrimidin-4-yl]-3-oxa-6-azabicyclo[3.1.1]heptane
    Show/Hide
Structure
Formula
C16H21N5O2
Molecular Weight
315.377
Canonical SMILES
Cc1ccnn1CCCOc1cc(ncn1)N1C2CC1COC2
    Show/Hide
InChI
InChI=1S/C16H21N5O2/c1-12-3-4-19-20(12)5-2-6-23-16-8-15(17-11-18-16)21-13-7-14(21)10-22-9-13/h3-4,8,11,13-14H,2,5-7,9-10H2,1H3
    Show/Hide
InChIKey
VARJLABYPSISMU-UHFFFAOYSA-N
Physicochemical Property
logP
1.42812
Rotatable Bonds
6
Heavy Atom Count
23
Polar Areas
65.3
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166634821
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05231, Very long chain fatty acid elongase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS